OncBioMune Pharmaceuticals, Inc Business Finance Contracts & Agreements
125 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Contribution Agreements (1)
- Escrow Agreements (1)
- Exchange Agreements (4)
- Guarantee Agreements (2)
- Guaranty Agreements (2)
- Note Agreements (36)
- Pledge Agreements (4)
- Purchase Agreements (24)
- Registration Rights Agreements (3)
- Security Agreements (7)
- Shareholders Agreements (2)
- Stock Agreements (8)
- Subscription Agreements (11)
- Trust Agreements (1)
- Warrant Agreements (17)
- Amended and Restated Security Agreement (Filed With SEC on August 21, 2023)
- Secured Convertible Promissory Note dated August 16, 2023 (Filed With SEC on August 21, 2023)
- Form of Security Agreement (Filed With SEC on December 1, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on December 1, 2022)
- Form of Common Stock Purchase Warrant (Filed With SEC on December 1, 2022)
- Form of Demand Note (Filed With SEC on September 16, 2022)
- Form of Securities Purchase Agreement for April 2022 (Filed With SEC on May 23, 2022)
- Form of Common Stock Purchase Warrant for April 2022 (Filed With SEC on May 23, 2022)
- Form of Convertible Promissory Note for April 2022 (Filed With SEC on May 23, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on February 3, 2022)
- Form of Common Stock Purchase Warrant 2 (Filed With SEC on February 3, 2022)
- Securities Purchase Agreement, dated November 1, 2021 (Filed With SEC on November 5, 2021)
- Form of Common Stock Purchase Warrant, issued November 1, 2021 (Filed With SEC on November 5, 2021)
- Form of Convertible Promissory Note, dated November 1, 2021 (Filed With SEC on November 5, 2021)
- Securities Purchase Agreement, dated July 30, 2021 (Filed With SEC on August 6, 2021)
- Common Stock Purchase Warrant, issued July 30, 2021 (Filed With SEC on August 6, 2021)
- Security Agreement, dated May 12, 2021 (Filed With SEC on May 19, 2021)
- Securities Purchase Agreement, dated May 12, 2021 (Filed With SEC on May 19, 2021)
- Common Stock Purchase Warrant, issued May 12, 2021 (Filed With SEC on May 19, 2021)
- Convertible Secured Promissory Note, dated May 12, 2021 (Filed With SEC on May 19, 2021)
- Form of Registration Rights Agreement (Filed With SEC on April 20, 2021)
- Form of Subscription Agreement (Filed With SEC on April 20, 2021)
- Securities Purchase Agreement, dated September 16, 2020, by and among OncBioMune Pharmaceuticals, Inc. and the Investor (Filed With SEC on September 22, 2020)
- Securities Purchase Agreement, dated June 5, 2020, by and among OncBioMune Pharmaceuticals, Inc. Cavalry Fund I LP and Lincoln Park Capital Fund, LLC (Filed With SEC on June 11, 2020)
- Exchange Agreement, dated June 5, 2020, by and between OncBioMune Pharmaceuticals, Inc. and Jonathan F. Head, Ph.D (Filed With SEC on June 11, 2020)
- Exchange Agreement, dated June 5, 2020, by and among OncBioMune Pharmaceuticals, Inc. and the Investors named therein (Filed With SEC on June 11, 2020)
- Exchange Agreement, dated June 5, 2020, by and among OncBioMune Pharmaceuticals, Inc. and the Investors named therein (Filed With SEC on June 11, 2020)
- Exchange Warrant, dated June 5, 2020 (Filed With SEC on June 11, 2020)
- Form of Warrant (Filed With SEC on June 11, 2020)
- Asset Purchase Agreement, dated May 12, 2020, between OncBioMune Pharmaceuticals, Inc. and Avant Diagnostics, Inc (Filed With SEC on May 13, 2020)
- Description of Capital Stock (Filed With SEC on March 25, 2020)
- Securities Purchase Agreement dated September 25, 2019 (Filed With SEC on November 19, 2019)
- Warrant dated September 25, 2019 (Filed With SEC on November 19, 2019)
- Note dated September 25, 2019 (Filed With SEC on November 19, 2019)
- Securities Purchase Agreement (Filed With SEC on August 6, 2019)
- Form of Warrant (Filed With SEC on August 6, 2019)
- Form of Note (Filed With SEC on August 6, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on July 18, 2019)
- Form of Warrant (Filed With SEC on July 18, 2019)
- Form of Note (Filed With SEC on July 18, 2019)
